Home > Publications database > An elusive debate on the evidence for RNA editing in SARS-CoV-2 > print |
001 | 288792 | ||
005 | 20240425122521.0 | ||
024 | 7 | _ | |a 10.1080/15476286.2024.2321032 |2 doi |
024 | 7 | _ | |a 1547-6286 |2 ISSN |
024 | 7 | _ | |a 1555-8584 |2 ISSN |
037 | _ | _ | |a DKFZ-2024-00475 |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Mattiuz, Giorgio |0 0000-0002-9668-1706 |b 0 |
245 | _ | _ | |a An elusive debate on the evidence for RNA editing in SARS-CoV-2 |
260 | _ | _ | |a Philadelphia, Pa. |c 2024 |b Taylor & Francis |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1709646428_9418 |2 PUB:(DE-HGF) |x Letter |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Di Giorgio, Salvatore |0 P:(DE-He78)d94ec9be53ad3f3e2633b3201f0ebe46 |b 1 |u dkfz |
700 | 1 | _ | |a Conticello, Silvestro G. |0 0000-0002-4244-1846 |b 2 |
773 | _ | _ | |a 10.1080/15476286.2024.2321032 |g Vol. 21, no. 1, p. 1 - 2 |0 PERI:(DE-600)2159587-2 |n 1 |p 1 - 2 |t RNA biology |v 21 |y 2024 |x 1547-6286 |
909 | C | O | |o oai:inrepo02.dkfz.de:288792 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)d94ec9be53ad3f3e2633b3201f0ebe46 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-07-17T13:52:00Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-07-17T13:52:00Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-07-17T13:52:00Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-25 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-25 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b RNA BIOL : 2022 |d 2023-10-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-25 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-25 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-25 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-25 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-25 |
920 | 1 | _ | |0 I:(DE-He78)D150-20160331 |k D150 |l D150 Immundiversität |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D150-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|